Private Equity, VC & Investor · vs · Private Equity, VC & Investor
Boston Seed vs SFC Capital
Structured technology and market comparison · 2026
Direct Feature Comparison
Boston Seed · vs · SFC CapitalPre-seed and seed venture firm for early-stage founders.
UK seed investor and SEIS/EIS angel fund manager.
Comparison Analysis
What is the main difference between Boston Seed and SFC Capital?
When comparing Boston Seed and SFC Capital, both platforms operate within the Private Equity, VC & Investor ecosystem. Boston Seed is positioned as Pre-seed and seed venture firm for early-stage founders, whereas SFC Capital focuses on UK seed investor and SEIS/EIS angel fund manager. Decision-makers evaluate both solutions when orchestrating their commercial monetization and technology stack.
What are the top alternatives to Boston Seed and SFC Capital?
When evaluating Boston Seed and SFC Capital, enterprise buyers also consider other platforms in Private Equity, VC & Investor. You can discover the full competitive landscape and evaluate other alternatives by viewing their respective footprint profiles on Polaris7.
Market Signals
Recent Market Signals & Activity: Boston Seed vs SFC Capital
Documented market movements, strategic partnerships, product releases, and regulatory developments mapped across Polaris7.
Boston Seed
Recent Signals
No recent market signals documented for Boston Seed in the current tracking window.
SFC Capital
Recent Signals
- ·Tech.eu (European Tech & Deals)Healthcare AI
Anemo Labs Raises £700K for AI E-Nose
London-based deeptech startup Anemo Labs has raised £700,000 in pre-seed funding to develop an electronic nose (e-nose) that combines sensor hardware with AI to detect volatile organic compounds (VOCs). The round was led by Zinc and SFC Capital with support from Innovate UK. Founded in 2025 by Koye Sodipo, the company initially targets healthcare applications, analyzing VOCs from urine for non-invasive disease screening. Anemo's in-house sampling platform can collect and label up to 5,000 smells daily, and early tests using the Sniffin' Sticks protocol achieved 84.15% accuracy across 12 scent categories. The funding will advance sensor chemistry, expand data collection, and support clinical validation.
- Anemo Labs raised £700,000 in pre-seed funding.
- The funding round was led by Zinc and SFC Capital, with support from Innovate UK.
- Anemo Labs is developing an electronic nose combining sensor hardware and AI to detect VOCs.
Compare their exact ecosystem overlaps.
Explore all deep relationships in Polaris7. Discover exactly which mutual clients, integrated technologies, and overlapping partners Boston Seed and SFC Capital share across the market ecosystem.